| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,933 |
13,270 |
$1.70M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,521 |
10,692 |
$1.43M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,304 |
8,556 |
$1.06M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,262 |
2,315 |
$762K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,162 |
3,177 |
$483K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
16,843 |
13,761 |
$455K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,686 |
3,449 |
$398K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
6,387 |
6,327 |
$379K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,881 |
2,656 |
$365K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,857 |
3,512 |
$294K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,907 |
10,110 |
$280K |
| 71046 |
Radiologic examination, chest; 2 views |
10,802 |
10,270 |
$275K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
8,590 |
2,531 |
$221K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,618 |
1,501 |
$207K |
| 76830 |
Ultrasound, transvaginal |
1,863 |
1,799 |
$180K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48,681 |
39,550 |
$179K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,210 |
1,094 |
$179K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,259 |
1,200 |
$156K |
| S9485 |
Crisis intervention mental health services, per diem |
348 |
299 |
$151K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,279 |
1,231 |
$146K |
| 84443 |
Thyroid stimulating hormone (TSH) |
16,125 |
15,537 |
$131K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,752 |
4,619 |
$125K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,735 |
4,605 |
$124K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,420 |
1,060 |
$122K |
| 80053 |
Comprehensive metabolic panel |
28,534 |
25,324 |
$120K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
6,405 |
6,355 |
$112K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,911 |
2,700 |
$107K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
841 |
787 |
$86K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,132 |
1,948 |
$84K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,046 |
4,944 |
$81K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,065 |
2,788 |
$80K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,545 |
1,474 |
$73K |
| 74018 |
|
1,825 |
1,724 |
$71K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,023 |
3,641 |
$71K |
| 99441 |
|
743 |
702 |
$70K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,689 |
2,379 |
$67K |
| 93971 |
|
365 |
338 |
$60K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
627 |
585 |
$56K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
11,646 |
11,344 |
$53K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,054 |
7,949 |
$51K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
20,412 |
16,444 |
$50K |
| 72100 |
|
1,448 |
1,406 |
$49K |
| 73562 |
|
1,753 |
1,531 |
$49K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
598 |
547 |
$49K |
| 87480 |
|
3,383 |
3,217 |
$48K |
| 87660 |
|
3,387 |
3,220 |
$48K |
| 87510 |
|
3,383 |
3,217 |
$47K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,299 |
3,138 |
$47K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,596 |
8,723 |
$41K |
| 76642 |
|
407 |
397 |
$39K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,873 |
1,517 |
$38K |
| 20610 |
|
294 |
244 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,705 |
9,807 |
$35K |
| 84484 |
|
6,732 |
5,545 |
$34K |
| 82728 |
|
4,276 |
3,945 |
$34K |
| 80061 |
Lipid panel |
16,768 |
16,323 |
$31K |
| 73630 |
|
1,141 |
1,073 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,688 |
2,773 |
$29K |
| 86803 |
|
3,024 |
2,960 |
$29K |
| 82607 |
|
3,885 |
3,779 |
$29K |
| 62323 |
|
131 |
127 |
$28K |
| ATP14 |
|
5,634 |
4,746 |
$28K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
312 |
198 |
$27K |
| 84439 |
|
5,444 |
5,235 |
$25K |
| ATP08 |
|
5,207 |
3,943 |
$25K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
55 |
49 |
$24K |
| 97161 |
|
520 |
501 |
$24K |
| 83690 |
|
6,495 |
5,761 |
$23K |
| 0002A |
|
841 |
836 |
$23K |
| 81025 |
|
4,622 |
4,300 |
$23K |
| 0001A |
|
1,000 |
993 |
$23K |
| 84702 |
|
1,868 |
1,412 |
$22K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
105 |
99 |
$21K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
273 |
178 |
$20K |
| 80050 |
General health panel |
1,486 |
1,355 |
$20K |
| 73610 |
|
633 |
574 |
$19K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
183 |
151 |
$18K |
| 76536 |
|
207 |
181 |
$17K |
| 59025 |
Fetal non-stress test |
95 |
60 |
$17K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
182 |
156 |
$17K |
| G0378 |
Hospital observation service, per hour |
971 |
783 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,752 |
5,213 |
$16K |
| 97597 |
|
640 |
411 |
$16K |
| 73130 |
|
526 |
447 |
$15K |
| 87070 |
|
2,889 |
2,667 |
$15K |
| 83735 |
|
4,824 |
3,878 |
$14K |
| 81003 |
|
12,557 |
11,466 |
$14K |
| 82948 |
|
6,125 |
3,825 |
$13K |
| 83550 |
|
3,084 |
2,880 |
$13K |
| 83540 |
|
3,838 |
3,602 |
$13K |
| ATP15 |
|
1,968 |
1,534 |
$12K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
151 |
125 |
$12K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
594 |
582 |
$11K |
| 82746 |
|
1,301 |
1,266 |
$10K |
| 97035 |
|
250 |
76 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
55 |
51 |
$10K |
| 73030 |
|
391 |
349 |
$9K |
| 94664 |
|
369 |
341 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
2,385 |
2,200 |
$9K |
| 76801 |
|
90 |
85 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
55,439 |
43,215 |
$9K |
| 84481 |
|
1,013 |
994 |
$9K |
| 81001 |
|
5,620 |
5,158 |
$9K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
618 |
551 |
$8K |
| 73110 |
|
215 |
206 |
$8K |
| 83880 |
|
860 |
779 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
976 |
897 |
$8K |
| 80076 |
|
6,687 |
6,135 |
$8K |
| 64635 |
|
51 |
39 |
$7K |
| 87186 |
|
1,857 |
1,746 |
$7K |
| 84403 |
|
309 |
306 |
$7K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
327 |
323 |
$7K |
| ATP17 |
|
4,568 |
4,062 |
$6K |
| 73502 |
|
224 |
218 |
$6K |
| 85610 |
|
4,546 |
3,281 |
$6K |
| 83605 |
|
1,453 |
1,255 |
$6K |
| 82043 |
|
3,179 |
3,133 |
$6K |
| 87340 |
|
804 |
791 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
312 |
286 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
7,258 |
6,413 |
$5K |
| 87040 |
|
660 |
565 |
$5K |
| 86140 |
|
1,789 |
1,631 |
$5K |
| 86850 |
|
905 |
801 |
$5K |
| 80081 |
|
78 |
78 |
$5K |
| 0011A |
|
165 |
164 |
$5K |
| 82570 |
|
1,803 |
1,708 |
$5K |
| 85651 |
|
2,180 |
2,030 |
$5K |
| 87077 |
|
1,332 |
1,255 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,294 |
2,087 |
$4K |
| ATP03 |
|
1,481 |
1,318 |
$4K |
| 76770 |
|
40 |
40 |
$4K |
| 85379 |
|
836 |
789 |
$4K |
| 86706 |
|
483 |
479 |
$4K |
| 84270 |
|
212 |
210 |
$4K |
| 77080 |
|
65 |
65 |
$3K |
| 86592 |
|
1,023 |
1,004 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
72 |
61 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
371 |
365 |
$3K |
| 0012A |
|
124 |
124 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,358 |
1,967 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,775 |
3,941 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,777 |
2,521 |
$3K |
| 86618 |
|
260 |
254 |
$3K |
| 73140 |
|
41 |
39 |
$3K |
| 97162 |
|
66 |
53 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
1,513 |
1,409 |
$3K |
| 99219 |
|
96 |
50 |
$3K |
| 86704 |
|
276 |
273 |
$3K |
| 87147 |
|
615 |
583 |
$2K |
| 77066 |
Tomosynthesis, mammo |
25 |
25 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
52 |
50 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
13 |
$2K |
| 94761 |
|
4,530 |
3,941 |
$2K |
| 86900 |
|
1,081 |
965 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
60 |
59 |
$2K |
| 86709 |
|
210 |
208 |
$2K |
| 86901 |
|
1,082 |
966 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,020 |
3,202 |
$2K |
| 71250 |
|
101 |
98 |
$2K |
| 97164 |
|
26 |
25 |
$1K |
| 84153 |
|
199 |
191 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
39 |
39 |
$1K |
| 94726 |
|
13 |
13 |
$1K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
44 |
25 |
$1K |
| 83516 |
|
107 |
96 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
14 |
13 |
$1K |
| 87205 |
|
539 |
497 |
$1K |
| 84703 |
|
220 |
215 |
$1K |
| 93041 |
|
853 |
815 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
16 |
12 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,378 |
2,128 |
$1K |
| 71271 |
|
13 |
13 |
$995.90 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
518 |
433 |
$950.46 |
| 83520 |
|
27 |
27 |
$927.48 |
| 88342 |
|
26 |
26 |
$909.80 |
| 85027 |
|
188 |
186 |
$799.40 |
| 94760 |
|
3,765 |
3,436 |
$705.60 |
| 77065 |
Tomosynthesis, mammo |
12 |
12 |
$654.88 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
960 |
658 |
$654.74 |
| 82950 |
|
165 |
165 |
$641.07 |
| 86038 |
|
66 |
64 |
$617.65 |
| 82784 |
|
104 |
96 |
$596.84 |
| 83001 |
|
38 |
38 |
$551.87 |
| ATP18 |
|
406 |
360 |
$537.53 |
| 84466 |
|
49 |
47 |
$486.30 |
| 84146 |
|
57 |
52 |
$433.38 |
| 64636 |
|
52 |
39 |
$408.24 |
| 82565 |
|
828 |
722 |
$375.46 |
| 83970 |
|
12 |
12 |
$372.19 |
| 72050 |
|
13 |
12 |
$362.05 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,344 |
1,075 |
$343.83 |
| 82248 |
|
223 |
198 |
$313.56 |
| 85730 |
|
132 |
123 |
$313.32 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
30 |
25 |
$298.80 |
| 87088 |
|
52 |
50 |
$285.23 |
| 72070 |
|
13 |
12 |
$283.92 |
| 82150 |
|
41 |
39 |
$204.28 |
| 83986 |
|
89 |
87 |
$203.18 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,035 |
839 |
$203.08 |
| 84560 |
|
111 |
103 |
$187.79 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,068 |
997 |
$179.24 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
951 |
830 |
$174.14 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,856 |
1,598 |
$166.08 |
| J2060 |
Injection, lorazepam, 2 mg |
158 |
109 |
$148.81 |
| 96376 |
|
2,008 |
992 |
$132.24 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
59 |
51 |
$119.55 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
12 |
12 |
$115.83 |
| ATP09 |
|
30 |
25 |
$89.60 |
| 80164 |
|
31 |
28 |
$74.10 |
| 84450 |
|
144 |
130 |
$72.81 |
| ATP07 |
|
24 |
24 |
$67.44 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
291 |
256 |
$56.83 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,317 |
2,989 |
$47.11 |
| 84460 |
|
300 |
263 |
$41.07 |
| 84520 |
|
448 |
384 |
$31.31 |
| 84100 |
|
135 |
100 |
$30.37 |
| ATP11 |
|
12 |
12 |
$27.33 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
928 |
870 |
$16.33 |
| 83615 |
|
25 |
24 |
$12.46 |
| 82947 |
|
29 |
28 |
$12.15 |
| 82040 |
|
14 |
13 |
$9.02 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
40 |
25 |
$0.90 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
126 |
121 |
$0.01 |
| 80320 |
|
447 |
373 |
$0.00 |
| 82550 |
|
13 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
28 |
28 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
115 |
71 |
$0.00 |
| 81015 |
|
16 |
14 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
18 |
14 |
$0.00 |
| J3490 |
Unclassified drugs |
16 |
15 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
39 |
34 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
115 |
110 |
$0.00 |
| 98960 |
|
66 |
56 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
396 |
374 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
170 |
156 |
$0.00 |
| 87150 |
|
17 |
17 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
57 |
25 |
$0.00 |